Diabetes-related endothelium and glycocalyx dysfunction is facilitated by HYAL1. A novel treatment strategy to stop the vascular consequences of diabetes may use HYAL1 inhibitors (48, 49). The gene discussed is HYAL1; the disease is diabetes mellitus.